⭐ Top Story
MSO Consolidation Surge: Big Players Lock In Market Share for Q3 2026
By Sheeba M. | May 18, 2026 MSO Consolidation Surge: Big Players Lock In Market Share for Q3 2026 TL;DR: Mega-cap MSOs are accelerating M&A
Canopy Growth Signals Turnaround as Q1 2026 Revenue Stabilizes
By Sheeba M. | May 15, 2026 Canopy Growth Signals Turnaround as Q1 2026 Revenue Stabilizes TL;DR: Canopy Growth’s Q1 2026 earnings show stabilized revenue
Green Thumb Industries Positions as the Dividend Play in Cannabis
By Sheeba M. | May 14, 2026 Green Thumb Industries Positions as the Dividend Play in Cannabis TL;DR: GTI’s strategic shift toward EBITDA margins and
📈 Top Movers

Supply Chain Pressures Hit Cannabis Prices in Q2
By Sheeba M. | May 5, 2026 Supply Chain Pressures Hit Cannabis Prices in Q2 TL;DR: Cannabis wholesale prices declined 8% across major markets as

Cannabis ETFs Rally on Licensing Expansion
By Sheeba M. | May 5, 2026 Cannabis ETFs Rally on Licensing Expansion TL;DR: Major cannabis ETFs surged 3.2% this week as state licensing boards

Cultivation Oversupply: Q2 Harvests Signal Market Softness Ahead
By Sheeba M. | May 5, 2026 Cultivation Oversupply: Q2 Harvests Signal Market Softness Ahead TL;DR: Early May harvests show 12% increase in cannabis supply
📰 Today's News
MSO Earnings Momentum Signals Shift in Federal Sentiment
By Sheeba M. | May 20, 2026 MSO Earnings Momentum Signals Shift in Federal Sentiment TL;DR: Multi-state operators posting 15-22% YoY revenue growth while maintaining
Cannabis ETF Rebalancing Could Reshape May Trading
By Sheeba M. | May 20, 2026 Cannabis ETF Rebalancing Could Reshape May Trading TL;DR: Quarterly rebalancing of major cannabis ETFs is underway—institutional capital flows
Curaleaf Dominates Q1: Profitability Push Narrows Competitors
By Sheeba M. | May 20, 2026 Curaleaf Dominates Q1: Profitability Push Narrows Competitors TL;DR: Curaleaf beat Q1 estimates with 23% YoY growth and positive
Canopy Growth Q1 Earnings Miss Signals Market Shift
By Sheeba M. | May 20, 2026 Canopy Growth Q1 Earnings Miss Signals Market Shift TL;DR: Canopy Growth’s Q1 miss on revenue expectations signals consolidation
Hemp-Derived Cannabinoids: The $2B Unregulated Market Wall Street Is Watching
By Sheeba M. | May 19, 2026 Hemp-Derived Cannabinoids: The $2B Unregulated Market Wall Street Is Watching TL;DR: Delta-8, Delta-10, and HHC are generating estimated
Cannabis Real Estate Crunch: Why Cultivation Margins Are Tightening
By Sheeba M. | May 19, 2026 Cannabis Real Estate Crunch: Why Cultivation Margins Are Tightening TL;DR: Rising lease rates and zoning restrictions are squeezing